Author: Kyrion Media Syndication

Creative Biolabs' one-stop microfluidic platform accelerates biomedical breakthroughs by streamlining chip innovation for faster, scalable, and physiologically relevant discoveries.

Creative Biolabs has announced a strategic expansion of its cancer vaccine research platforms, focusing on the sophisticated design and synthesis of tumor-associated carbohydrate antigens (TAGAs).